Wang C J, Yuen L T, Lee C L, Kay N, Soong Y K
Department of Obstetrics and Gynecology, Division of Gynecologic Endoscopy, Chang Gung Memorial Hospital, Linkou Medical Center and Chang Gung University College of Medicine, 5 Fu-Hsin Street, Kwei-Shan Tao-Yuan, 33305, Tao-Yuan, Taiwan.
Surg Endosc. 2006 Sep;20(9):1427-30. doi: 10.1007/s00464-005-0509-7. Epub 2006 May 15.
The goal of this study was to examine the safety and feasibility of laparoscopic myomectomy (LM) for the management of symptomatic intramural uterine fibroids with weight greater than 80 g as compared to those less than 80 g.
In a prospective comparative study, 176 women with symptomatic uterine fibroids were scheduled for LM. They were divided into two groups, one with main uterine fibroid (intramural type) weight greater than 80 g and the other with fibroid weight less than 80 g. Outcome measures for the two groups were studied in terms of operation time, amount of blood loss, requirement of blood transfusion, and length of hospital stay.
Operation time and amount of blood loss were significantly greater in the group with fibroid > or = 80 g than in the group < 80 g (121.5 +/- 58.9 min versus 79.1 +/- 28.6 min, p < 0.001; and 346.3 +/- 299.6 ml versus 123.0 +/- 89.7 ml, p < 0.001, respectively). However, there was no difference in the length of hospital stay and overall incidence of operative complications between these two groups. None of the women had any major complications. Nevertheless, 11 minor complications were noted, including two pelvic abscesses requiring a second laparoscopic treatment. There was no incidence of switching to laparatomy during the operation. Extreme intraoperative hemorrhage of more than 1000 ml occurred in 8 patients; however, all progressed to full recovery after blood transfusion. Rate of blood transfusion was significantly lower in the group with fibroid < 80 g (3.2% versus 22.1%, p < 0.001).
Despite the increased operation time and blood loss, LM can be safely performed in the treatment of large uterine fibroid. However, high risk of blood transfusion in these patients has to be kept in mind.
本研究的目的是探讨与肌瘤重量小于80克的患者相比,腹腔镜子宫肌瘤切除术(LM)治疗症状性肌壁间子宫肌瘤且重量大于80克的安全性和可行性。
在一项前瞻性对照研究中,176例有症状子宫肌瘤的女性计划接受LM手术。她们被分为两组,一组主要子宫肌瘤(肌壁间型)重量大于80克,另一组肌瘤重量小于80克。从手术时间、失血量、输血需求和住院时间方面研究两组的结局指标。
肌瘤重量≥80克组的手术时间和失血量显著多于<80克组(分别为121.5±58.9分钟对79.1±28.6分钟,p<0.001;346.3±299.6毫升对123.0±89.7毫升,p<0.001)。然而,两组的住院时间和手术并发症总发生率没有差异。所有女性均未发生任何严重并发症。不过,记录到11例轻微并发症,包括2例盆腔脓肿需要再次进行腹腔镜治疗。手术过程中没有转为开腹手术的情况。8例患者术中出现超过1000毫升的严重出血;然而,所有患者输血后均完全康复。肌瘤重量<80克组的输血率显著较低(3.2%对22.1%,p<0.001)。
尽管手术时间和失血量增加,但LM可安全用于治疗大型子宫肌瘤。然而,必须牢记这些患者输血风险较高。